Suchergebnisse - "Laharie, David"

PubPharm (19)

1

The risk of COVID-19 in IBD patients is increased by urban living and is not influenced by disease activity or intravenous biologics

enthalten in: Frontiers in immunology | 2023

von Lelong, M. | Josien, R. | Coste-Burel, M. | +23

2

Comparative real-world effectiveness of vedolizumab and ustekinumab for patients with ulcerative colitis : a GETAID multicentre cohort study

enthalten in: Scandinavian journal of gastroenterology | 2022

von Meyer, A. | Fumery, M. | Peyrin-Biroulet, L. | +22

3

Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn's disease : a multicentre retrospective study

enthalten in: BMC gastroenterology | 2022

von Rayer, C. | Nachury, M. | Bourreille, A. | +10

ErratumIn: BMC Gastroenterol. 2023 Feb 2;23(1):31. - PMID 36732693

4

Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease

enthalten in: United European gastroenterology journal | 2021

von Buisson, A. | Nancey, S. | Manlay, L. | +11

5

Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients : a multicentre cohort study

enthalten in: Alimentary pharmacology & therapeutics | 2021

von Wils, P. | Seksik, P. | Stefanescu, C. | +68

CommentIn: Aliment Pharmacol Ther. 2021 Feb;53(3):450-451. - PMID 33428251

6

Editorial : biologics in the therapy of Crohn's disease-the fog clears

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Laharie, D. | Riviere, P.

CommentOn: Aliment Pharmacol Ther. 2020 Aug;52(4):669-681. - PMID 32656800

7

Maintenance of Remission Among Patients With Inflammatory Bowel Disease After Vedolizumab Discontinuation : A Multicentre Cohort Study

enthalten in: Journal of Crohn's & colitis | 2020

von Martin, A. | Nachury, M. | Peyrin-Biroulet, L. | +62

8

Comparative efficacy and safety of vedolizumab and infliximab in ulcerative colitis after failure of a first subcutaneous anti-TNF agent : a multicentre cohort study

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Hupé, M. | Rivière, P. | Nancey, S. | +11

CommentIn: Aliment Pharmacol Ther. 2020 Jun;51(11):1198-1199. - PMID 32424929

9

Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2020

von Lair-Mehiri, L. | Stefanescu, C. | Vaysse, T. | +15

10

A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Dulai, P. | Amiot, A. | Peyrin-Biroulet, L. | +95

CommentIn: Aliment Pharmacol Ther. 2020 Apr;51(7):738-739. - PMID 32162371